The research data is related to the project "From lipids to lymphocytes: research on the role of lipidomics and checkpoints in primary glomerulopathies," funded by National Science Centre (Poland) under the MINIATURA 8 call (no. 2024/08/X/NZ5/00659).
The dataset contains plasma lipid profile results from patients and control subjects obtained using LC-MS/MS. It includes panels for acylcarnitines, cholesterol esters, di- and triacylglycerols, and glycerophospholipids (including lysophosphatidylcholine and phosphatidylcholine, including ether forms). Each result is accompanied by a quality status (e.g., Valid, <LLOQ, <LOD, >ULOQ).
The data are organized in a "one sample = one row" format, with fields identifying the sample and group. The dataset is designed for comparative analyses, biomarker discovery, and integration with immunological data in primary glomerulopathies.
Method Information: Assays were performed using the AbsoluteIDQ® p400 HR kit (Biocrates Life Sciences AG, Innsbruck, Austria). Signal acquisition and analysis details were standardized for all samples, enabling comparability of results between cohorts.
Legend: abbreviations and notation for the lipidomics dataset
ID – sample identifier; AC – acylcarnitines; CE – cholesterol esters; DG – diacylglycerols; TG – triacylglycerols; LPC – lysophosphatidylcholine; PC – phosphatidylcholine; PC-O – ether-linked PC (plasmalogens); DG-O – ether-linked DG; Hexose – sum of hexoses; notation (x:y) – number of carbon atoms:number of double bonds; _status – QC status column: Valid – reliable (quantitative) result; <LOD – below limit of detection; <LLOQ – below lower limit of quantification (approximate); >ULOQ – above upper limit of quantification; n/a – not available;
